Xeris Biopharma Holdings, Inc. (XERS)
8.16
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 15:25
Xeris Biopharma Holdings Market Cap : 1.417B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.417B |
| September 16, 2026 | 1.351B |
| September 15, 2026 | 1.300B |
| September 14, 2026 | 1.314B |
| September 11, 2026 | 1.293B |
| September 10, 2026 | 1.331B |
| September 09, 2026 | 1.338B |
| September 08, 2026 | 1.472B |
| September 04, 2026 | 1.481B |
| September 03, 2026 | 1.491B |
| September 02, 2026 | 1.489B |
| September 01, 2026 | 1.463B |
| August 31, 2026 | 1.465B |
| August 28, 2026 | 1.472B |
| August 27, 2026 | 1.493B |
| August 26, 2026 | 1.507B |
| August 25, 2026 | 1.517B |
| August 24, 2026 | 1.517B |
| August 21, 2026 | 1.510B |
| August 20, 2026 | 1.493B |
| August 19, 2026 | 1.524B |
| August 18, 2026 | 1.536B |
| August 17, 2026 | 1.479B |
| August 14, 2026 | 1.493B |
| August 13, 2026 | 1.446B |
| Date | Value |
|---|---|
| August 12, 2026 | 1.474B |
| August 11, 2026 | 1.456B |
| August 10, 2026 | 1.387B |
| August 07, 2026 | 1.377B |
| August 06, 2026 | 1.278B |
| August 05, 2026 | 1.408B |
| August 04, 2026 | 1.422B |
| August 03, 2026 | 1.482B |
| July 31, 2026 | 1.394B |
| July 30, 2026 | 1.453B |
| July 29, 2026 | 1.446B |
| July 28, 2026 | 1.422B |
| July 27, 2026 | 1.417B |
| July 24, 2026 | 1.436B |
| July 23, 2026 | 1.451B |
| July 22, 2026 | 1.446B |
| July 21, 2026 | 1.515B |
| July 20, 2026 | 1.484B |
| July 17, 2026 | 1.519B |
| July 16, 2026 | 1.500B |
| July 15, 2026 | 1.501B |
| July 14, 2026 | 1.429B |
| July 13, 2026 | 1.408B |
| July 10, 2026 | 1.439B |
| July 09, 2026 | 1.487B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zevra Therapeutics, Inc. | 692.82M |
| Aclaris Therapeutics, Inc. | 755.75M |
| ANI Pharmaceuticals, Inc. | 1.769B |
| Corcept Therapeutics, Inc. | 11.89B |
| Veru, Inc. | 41.09M |
Market Cap Related Metrics
| PS Ratio | 4.307 |
| Price to Free Cash Flow | 25.95 |
| Price | 8.16 |
| Earnings Yield | -1.25% |
| Operating PE Ratio | 39.48 |
| Normalized PE Ratio | 365.92 |